“life-sciences” Archives

in
Entry Author Date Location
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
Mary Lou Jepsen, Moonshots, and the Human Impact of Innovation 03/29/17 San Diego
ViaCyte Working with Gore to Improve its Synthetic Pancreas Device 03/29/17 San Diego
With New Data, Vertex Touts Backbone Of Future Cystic Fibrosis Drugs 03/28/17 Boston
FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price 03/28/17 New York
IBRI, Dow Agrosciences, Lilly Partner on Molecular Safety Database  03/28/17 Indiana
Exact Sciences Shares Higher After Aetna Expands Cologuard Coverage 03/27/17 Wisconsin
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
After $1M NEI Grant, ONL Therapeutics Closer to Clinical Trials 03/27/17 Detroit Ann Arbor
Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO 03/27/17 Boston
Eli Lilly Reveals $850M Capital Spending Plan for Indiana and Beyond 03/24/17 Indiana
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
Today Only: Save $70 for Human Impact of Innovation on April 19th 03/23/17 National
Amid Gender Gap Talk, Mentor Network Emerges For Women In Health, Bio 03/23/17 National
Sanders, Cummings to PTC: Price Duchenne Steroid at Import Cost 03/22/17 New York
Texas Roundup: SXSW Odds & Ends, Dosh, Mythic, Peloton, & More 03/22/17 Texas
BioClin Gets $30M to Back More Bladder Cancer Drug Trials 03/22/17 San Francisco
Early Bird Rate Ending for What’s Hot in Cancer Immunotherapy 2017 on 6/14 03/22/17 Seattle
After a Clinical Trial Death, FDA OKs New Tests of Akashi’s Duchenne Drug 03/22/17 Boston
Join David Baltimore, Nicole Glaros, Nathan Myhrvold, & More at Our Napa Summit 03/22/17 National
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
Join Varmus, Foley & More at NY Biotech Seizes the Momentum on May 31 03/21/17 New York
Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs 03/20/17 Boston
No Pain, No High: Nektar’s Opioid Drug Hits Trial Goals, Lifts Shares 03/20/17 San Francisco
Aetion’s Medical Evidence Software Scores $11M in Funding 03/20/17 New York
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More 03/17/17 National
Page 1 of 318 next page »